Entries by mercuric

MErCuRIC celebrates International Clinical Trials Day 2018

In celebration of International Clinical Trials Day on 18 May 2018, an exhibition showcased cancer clinical studies in the Northern Ireland Cancer Centre. MErCuRIC and all open clinical studies where there was local leadership were promoted. Patient representatives Margaret Grayson and Dr Edward Goodall were part of the team from the Northern Ireland Cancer Research Consumer Forum (NICRCF), […]

MErCuRIC presented at the 2018 All-Ireland Colorectal Cancer Conference, Dublin

MErCuRIC will feature in a presentation facilitated by Dr Austin Duffy of the Mater Misericordiae Hospital, Dublin at the 2018 All Ireland Colorectal Cancer Conference. Dr Duffy’s talk is “Clinical Trials in Colorectal Cancer” will take place on Saturday, May 19th at the Gibson Hotel, Dublin, Ireland. This 2-day conference assembles healthcare professionals with a […]

Margaret Grayson receives Iris Colvin Lifetime Achievement Award for Health

On April 21, 2018, valued MErCuRIC PPI team member Margaret Grayson received the Iris Colvin Lifetime Achievement Award for Health, presented by the Women’s Forum NI (Northern Ireland, UK) at Belfast City Hall. The award is bestowed in recognition of the lifetime achievement of a woman in service, dedication and commitment, and in this instance to […]

‘Trialling tailored treatments for colorectal cancer’: A European Commission Research & Innovation Success Story

MErCuRIC was featured as a Horizon 2020 Success Story on the European Commission’s Policies, information and services webpage on April 14, 2018. Below is an excerpt from the story. “Made-to-measure treatments are becoming possible because of the growing understanding of the genetic and molecular nature of cancers and disease in general,” says Coordinator Sandra Van […]

MErCuRIC study published in Molecular Cancer Therapeutics

The MErCuRIC study ‘The unfolded protein response: a novel therapeutic target for poor prognostic BRAF mutant colorectal cancer’ has been recently published in Molecular Cancer Therapeutics. The body of research by Nicholas Forsythe, Alaa Refaat, Arman Javadi, Hajrah Khawaja, Jessica-Anne Weir, Heba Emam, Wendy L Allen, Frank Burkamp, Vlad Popovici, Puthen V Jithesh, Claudio Isella, Melissa J […]

MErCuRIC team from RECETOX, Masarykova Univerzita publish study results

‘A critical comparison of topology-based pathway analysis methods’ authored by the team of Dr Vlad Popovici at the Research Centre for Toxic Compounds in the Environment (RECETOX), Masarykova Univerzita has been recently published in PLoS One. The body of research by Ivana Ihnatova, Vlad Popovici and Eva Budinska appeared online on 25 January 2018. Abstract […]

EuropaColon features a MErCuRIC patient’s perspective and our clinical trial

Through networking and information sharing, MErCuRIC is building bridges with colorectal cancer, personalised medicine and other stakeholder initiatives. Currently, MErCuRIC is featured on the EuropaColon website with our first patient perspective story written by Ed Goodall. Special thanks to Ed! To read the entire story, click here. In addition, please visit our new web page for patient […]

Reflections from EAPM 2017 where MErCuRIC PPI was Highlighted

The 1st European Alliance for Personalised Medicine (EAPM) Congress was held in Belfast in November 2017 where Margaret Grayson presented MErCuRIC’s mission and objectives with an emphasis of the Public and Patient Involvement (PPI) aspects of the project. Margaret, Chair, NI Cancer Research Consumer Forum commented, “The conference was a great opportunity for listening, talking, sharing and […]